Cue Biopharma, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CUE Nasdaq 2836 www.cuebiopharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cue Biopharma, Inc.

Strength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength? - Mar 17th, 2025 9:33 am
Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Nov 29th, 2024 9:30 pm
Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference - Nov 25th, 2024 1:00 pm
Cue Biopharma Third Quarter 2024 Earnings: Beats Expectations - Nov 17th, 2024 2:27 pm
Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Tops Revenue Estimates - Nov 14th, 2024 10:25 pm
Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights - Nov 14th, 2024 9:05 pm
Cue Biopharma Announces Strategic Organizational Transition - Nov 14th, 2024 1:00 pm
Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference - Nov 12th, 2024 1:00 pm
Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting - Nov 8th, 2024 6:30 pm
Cue Biopharma (NASDAQ:CUE) adds US$31m to market cap in the past 7 days, though investors from three years ago are still down 89% - Oct 8th, 2024 10:13 am
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting - Oct 4th, 2024 1:00 pm
Cue Biopharma Announces Pricing of $12.0 Million Public Offering - Sep 27th, 2024 3:26 am
Cue Biopharma Announces Proposed Public Offering - Sep 27th, 2024 3:10 am
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer - Sep 9th, 2024 12:00 pm
Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference - Sep 3rd, 2024 12:00 pm
Q2 2024 Cue Biopharma Inc Earnings Call - Aug 20th, 2024 1:36 pm
Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights - Aug 19th, 2024 8:05 pm
Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates - Aug 14th, 2024 11:45 pm
Cue Biopharma to Host Business Update Call and Webcast - Aug 13th, 2024 12:00 pm
Cue Biopharma downsizes to focus on autoimmune pipeline - Jul 26th, 2024 2:13 pm